Curti, Antonio

The P2X7 Receptor: A Key Player in IL-1 Processing and Release

Ferrari, D., Pizzirani, C., Adinolfi, E., Lemoli, R. M., Curti, A., Idzko, M., Panther, E., & Di Virgilio, F. (2006) · The Journal of Immunology

Adenosine and Purinergic SignalingInflammasome and immune disorders

Cited by 1,025

BCR-ABL Independent Mechanisms of Resistance in Chronic Myeloid Leukemia

Loscocco, F., Visani, G., Galimberti, S., Curti, A., & Isidori, A. (2019) · Frontiers in Oncology

Chronic Myeloid Leukemia TreatmentsAcute Myeloid Leukemia Research

Cited by 120

Sunitinib Exerts In Vitro Immunomodulatory Activity on Sarcomas via Dendritic Cells and Synergizes With PD-1 Blockade

Ocadlikova, D., Lecciso, M., Broto, J. M., Scotlandi, K., Cavo, M., Curti, A., & Palmerini, E. (2021) · Frontiers in Immunology

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 31

KAT2A complexes ATAC and SAGA play unique roles in cell maintenance and identity in hematopoiesis and leukemia

Arede, L., Foerner, E., Wind, S., Kulkarni, R., Domingues, A. F., Giotopoulos, G., Kleinwaechter, S., Mollenhauer-Starkl, M., Davison, H., Chandru, A., et al. (2022) · Blood Advances

Acute Myeloid Leukemia ResearchGenomics and Chromatin Dynamics

Cited by 25

Siremadlin (HDM201) Is Well Tolerated and Demonstrates Clinical Activity in Patients with Acute Myeloid Leukemia Who Have Relapsed after Allogeneic Stem Cell Transplantation: A Subset Analysis of Safety and Preliminary Efficacy

Stein, E. M., Chromik, J., Carpio, C., Mous, R., Kiladjian, J.-J., Alatrash, G., Curti, A., Craddock, C., Schmid, C., Zeiser, R., et al. (2021) · Blood

Acute Myeloid Leukemia ResearchCancer-related Molecular Pathways

Cited by 8